Baird analyst Eric Coldwell raised the firm’s price target on Cardinal Health (CAH) to $250 from $232 and keeps an Outperform rating on the shares. The firm updated its model following its conference presentation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health price target raised to $240 from $230 at Leerink
- Midday Fly By: JPMorgan reports mixed Q4, L3Harris to form new missile company
- Morning Movers: L3Harris Technologies jumps after DoW investment
- Cardinal Health Raises 2026 EPS Outlook, Highlights Growth
- Cardinal Health raises FY26 EPS view to at least $10.00 from $9.65-$9.85